Boston, Massachusetts Clinical Trials
A listing of Boston, Massachusetts clinical trials actively recruiting patient volunteers.
Found 30 clinical trials
Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer
The primary objective of this study is to evaluate the safety and tolerability of BGT007H cell therapy in patients with recurrent/refractory pancreatic cancer.
- 0 views
- 13 May, 2025
- 1 location
- Online study
A THREE-MONTH CLINICAL STUDY TO ASSESS PARTICIPANT EXPERIENCE, WELLNESS, PHYSIOLOGICAL AND BLOOD BIOMARKERS FOLLOWING DAILY NUTRAMETA™ ADMINISTRATION WITH A THREE-MONTH EXTENSION
This study is evaluating an over-the-counter supplement for weight loss that uses a combination of natural ingredients that have been safely used by humans for hundreds of years. Our research suggests that a unique combination of those ingredients can have a metabolic and neurological benefit if taken over time.
- 0 views
- 03 Sep, 2024
- 1 location
- Online study
The 23andMe Lung Cancer Genetic Study
the lung cancer community and scientists want to learn more about the genetics of people diagnosed with lung cancer and help improve care in the future. While research and targeted therapies have provided hope and progress for many, we still don't know much about the disease and its causes. Your …
- 0 views
- 09 Jan, 2025
- 1 location
- Online study
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid
The primary purpose of this study is to determine whether treatment with lecanemab is superior to placebo on change from baseline of the Preclinical Alzheimer Cognitive Composite 5 (PACC5) at 216 weeks of treatment (A45 Trial) and to determine whether treatment with lecanemab is superior to placebo in reducing brain …
- 0 views
- 10 Jan, 2025
- +105 other locations
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
The primary goal of this study is to assess the safety and tolerability of mRNA-4359 administered alone and in combination with pembrolizumab.
- 0 views
- 10 Jan, 2025
- +24 other locations
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors
A prospective, open-label, multi-cohort, non-randomized, multicenter Phase 2 study evaluating adoptive cell therapy (ACT) with TIL LN-144 (Lifileucel)/LN-145 in combination with checkpoint inhibitors or TIL LN-144 (Lifileucel)/LN-145/LN-145-S1 as a single agent therapy.
- 0 views
- 10 Jan, 2025
- +16 other locations
A Study of an MMSET Inhibitor in Patients with Relapsed and Refractory Multiple Myeloma
A Phase I study to evaluate the safety of a novel, orally available, selective, and potent small molecule inhibitor of the histone lysine methyl transferase MMSET (also known as NSD2/WHSC1) to prevent the dimethylation of H3K36 in adult patients with relapsed or refractory multiple myeloma (RRMM).
- 0 views
- 25 Jun, 2025
- +3 other locations
A Study of Multiple Therapies in Biomarker-Selected Patients With Resectable Stages IB-III Non-Small Cell Lung Cancer
This trial will evaluate the efficacy and safety of various therapies in patients with Stage IB, IIA, IIB, IIIA, or selected IIIB resectable and untreated non-small cell lung cancer (NSCLC) tumors that meet protocol-specified biomarker criteria
- 0 views
- 10 Jan, 2025
- +25 other locations
Patient-centered, Optimal Integration of Survivorship and Palliative Care
The goal of this study is to develop and test the feasibility of a supportivecare model (POISE) for patients with metastatic Non-small Cell Lung Cancer(NSCLC). The main questions areis POISE feasible to deliver and acceptable to patientswhat is the effect of POISE on the distress patients feel related to their …
- 0 views
- 10 Jan, 2025
- 1 location
Immune and Genomic Markers in ALK+ NSCLC
The purpose of this research study is to obtain and study clinical history, and tissue and saliva specimens if available from participants with Anaplastic Lymphoma Kinase-ALK+ Non-Small Lung Cancer(NSCLC)
- 0 views
- 12 Mar, 2025
- 1 location